Cyclobenzaprine
Previous
Next
Most Commonly Used
Cyclobenzaprine 5mg Tab
Cipla USA, Inc
Cipla USA, Inc
Pill Identification:
IG
|
282
Cyclobenzaprine 5mg Tab
Par Pharmaceuticals, an Endo Company
Par Pharmaceuticals, an Endo Company
Pill Identification:
V
|
2631
Cyclobenzaprine 5mg Tab

Cyclobenzaprine 7.5mg Tab

Cyclobenzaprine 5mg Tab
Camber Pharmaceuticals Inc
Camber Pharmaceuticals Inc
Pill Identification:
IG
|
282
Also See:
- Answers to Frequently-Asked Questions (FAQs)
- Other Class Related Drugs
- Additional Patient Usage Statistics
Take Action:
Overview Information on Cyclobenzaprine

Pharmacist Tip
Cyclobenzaprine is a medicine that your doctor may prescribe as a part of combination therapy, along with physical therapy and rest, to help with your muscle relaxation problems. Cyclobenzaprine should only be taken for a short period of time.
Your doctor can prescribe cyclobenzaprine as a tablet or extended-release capsule. Cyclobenzaprine comes as the brand names Amrix®, Fexmid®, and Flexeril®.
Unless your doctor tells you to, you should not take cyclobenzaprine for more than two to three weeks at a time.
If you miss a dose of cyclobenzaprine, take it as soon as you remember, unless it's almost time for your next dose of cyclobenzaprine. In this case, take your regularly scheduled dose of cyclobenzaprine and skip the missed dose. Your doctor prescribed cyclobenzaprine to treat your condition. Do not share cyclobenzaprine with anyone else, even if they tell you they have the same condition as you.
Clinical Review by Jodi Grimm, RPh and Ann Ciemnoczolowski, MS, ELS on May 15, 2013
Your doctor can prescribe cyclobenzaprine as a tablet or extended-release capsule. Cyclobenzaprine comes as the brand names Amrix®, Fexmid®, and Flexeril®.
Unless your doctor tells you to, you should not take cyclobenzaprine for more than two to three weeks at a time.
If you miss a dose of cyclobenzaprine, take it as soon as you remember, unless it's almost time for your next dose of cyclobenzaprine. In this case, take your regularly scheduled dose of cyclobenzaprine and skip the missed dose. Your doctor prescribed cyclobenzaprine to treat your condition. Do not share cyclobenzaprine with anyone else, even if they tell you they have the same condition as you.
Clinical Review by Jodi Grimm, RPh and Ann Ciemnoczolowski, MS, ELS on May 15, 2013
Cyclobenzaprine is a medicine that your doctor may prescribe as a part of combination therapy, along with physical therapy and rest, to help with your muscle relaxation problems. Cyclobenzaprine should only be taken for a short period of time.
Your doctor can prescribe cyclobenzaprine as a tablet or extended-release capsule. Cyclobenzaprine comes as the brand names Amrix®, Fexmid®, and Flexeril®.
Unless your doctor tells you to, you should not take cyclobenzaprine for more than two to three weeks at a time.
If you miss a dose of cyclobenzaprine, take it as soon as you remember, unless it's almost time for your next dose of cyclobenzaprine. In this case, take your regularly scheduled dose of cyclobenzaprine and skip the missed dose. Your doctor prescribed cyclobenzaprine to treat your condition. Do not share cyclobenzaprine with anyone else, even if they tell you they have the same condition as you.
Clinical Review by Jodi Grimm, RPh and Ann Ciemnoczolowski, MS, ELS on May 15, 2013
Your doctor can prescribe cyclobenzaprine as a tablet or extended-release capsule. Cyclobenzaprine comes as the brand names Amrix®, Fexmid®, and Flexeril®.
Unless your doctor tells you to, you should not take cyclobenzaprine for more than two to three weeks at a time.
If you miss a dose of cyclobenzaprine, take it as soon as you remember, unless it's almost time for your next dose of cyclobenzaprine. In this case, take your regularly scheduled dose of cyclobenzaprine and skip the missed dose. Your doctor prescribed cyclobenzaprine to treat your condition. Do not share cyclobenzaprine with anyone else, even if they tell you they have the same condition as you.
Clinical Review by Jodi Grimm, RPh and Ann Ciemnoczolowski, MS, ELS on May 15, 2013